Cergutuzumab amunaleukin

Cergutuzumab amunaleukin Uses, Dosage, Side Effects, Food Interaction and all others data.

Cergutuzumab amunaleukin is under investigation in clinical trial NCT02004106 (A Study to Evaluate Safety, Pharmacokinetics, and Efficacy of RO6895882 in Participants With Advanced and/or Metastatic Solid Tumors).

Trade Name Cergutuzumab amunaleukin
Generic Cergutuzumab amunaleukin
Cergutuzumab amunaleukin Other Names Cergutuzumab amunaleukin
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
Cergutuzumab amunaleukin
Cergutuzumab amunaleukin

Innovators Monograph

You find simplified version here Cergutuzumab amunaleukin


*** Taking medicines without doctor's advice can cause long-term problems.
Share